Back

Identification of novel biomarkers for predicting atrial fibrillation outcomes in patients with cardiovascular risk factors

25 April 2021 (16:15 - 17:10)
Organised by:
Congress Presentation Part of: Pathophysiology of atrial fibrillation and beyond I Pathophysiology and Mechanisms EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Alya Khashaba

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Impact of atrial fibrillation pattern on left atrial appendage closure: insights from the prospective LAARGE registry
Doctor S. Kany (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Sacubitril/valsartan therapy and supraventricular arrhythmias detected through remote monitoring in heart failure patients
Associate Professor F. Guerra (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
RNA-seq profiling of the atrial transcriptome reveals gender-specific patterns and interactions with atrial fibrillation and heart failure
Mr D. Balamurali (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive fibrosis
Mr L. Hopman (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of diabetes mellitus in patients with atrial fibrillation
Doctor A. Papazoglou (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of atrial fibrillation and beyond I

The Event

Event poster

EHRA 2021

25 April 2021 16:15 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
Basic science and arrhythmia pathophysiology
thumbnail
Congress Session
How to manage atrial fibrillation in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources